Fabry Disease NFZ — 36 facilities in 31 cities

Fabry disease is a rare lysosomal storage disorder caused by deficiency of alpha-galactosidase A enzyme, leading to glycosphingolipid accumulation in organs. It causes neuropathic pain, kidney, heart, and brain damage. NFZ covers enzymatic and genetic diagnostics, as well as enzyme replacement therapy (ERT) or chaperone therapy through a drug program.